Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL:
CONTENTS Issue #379
Consent is the key in the recording, use and sharing of genetic information and test results
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Consent is the key in the recording, use and sharing of genetic information and test results
9 October 2006 - by Professor Peter Farndon
You can't draw and record a family tree without the permission of all the members shown on it - the Data Protection Act won't allow it''Medical confidentiality won't allow my laboratory to release a DNA result to allow genetic testing to be offered to another family member'.'You can't... [Read More]
$3 billion stem cell research plan
5 October 2006 - by Dr Laura Bell
The California Institute for Regenerative Medicine has issued a plan for spending $3 billion on stem cell research over the next ten years. The Institute's leaders are forewarning that it will take time to make significant progress and maintain that $3 billion is not enough to fully... [Read More]
RNA Interference wins Nobel Prize
5 October 2006 - by Dr Laura Bell
Two US scientists have been awarded the Nobel Prize for Medicine for discovering a fundamental mechanism which regulates the expression of genes, called RNA interference (RNAi). Andrew Fire of the Stanford School of Medicine and Craig Mello of the University of Massachusetts Medical School won a shared... [Read More]
Gene-based anti-depressant treatment
6 October 2006 - by Dr Laura Bell
Two studies published this week in the journal Science, and in the Journal of the American Medical Association (JAMA) may help identify the most effective type of anti-depressant medication for individuals, depending on their genetic make up. Currently, treating people for depression or chronic anxiety is a... [Read More]
British stem cell scientists seek licence to create chimeras
9 October 2006 - by Heidi Nicholl
British scientists from three separate research centres have announced their intention to submit simultaneous proposals to the Human Fertilisation and Embryology Authority (HFEA) later this month seeking a licence to create human-animal chimeras. The researchers - based in London, Newcastle and Edinburgh - are seeking approval to carry out... [Read More]
NHS Trusts fail to deliver IVF pledge
9 October 2006 - by Antony Starza-Allen
A survey conducted by a UK newspaper, The Independent, has revealed that nine out of ten NHS Primary Care Trusts (PCTs) have failed to deliver their pledge of three free IVF treatments for infertile couples, as recommended by the National Institute for Health and Clinical Excellence (NICE... [Read More]
$10m dollar race to sequence 100 genomes in 10 days
9 October 2006 - by Antony Starza-Allen
The X Prize Foundation is offering $10m to the first private team that is able to sequence 100 human genomes in just ten days. It would currently take months, at the cost of millions of dollars, to sequence an individual human genome. Francis Collins, director of the... [Read More]
New breast cancer risk gene discovered
9 October 2006 - by Dr Jess Buxton
Researchers based at the UK's Institute of Cancer Research (ICR) have discovered that women who inherit a faulty version of a gene called BRIP1 have an increased risk of developing breast cancer. The scientists, who reported the findings at the National Cancer Research Institute conference and... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX